Anaptysbio (ANAB) Current Assets: 2016-2025
Historic Current Assets for Anaptysbio (ANAB) over the last 9 years, with Sep 2025 value amounting to $330.6 million.
- Anaptysbio's Current Assets fell 26.31% to $330.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $330.6 million, marking a year-over-year decrease of 26.31%. This contributed to the annual value of $431.9 million for FY2024, which is 6.16% up from last year.
- As of Q3 2025, Anaptysbio's Current Assets stood at $330.6 million, which was up 13.27% from $291.9 million recorded in Q2 2025.
- Over the past 5 years, Anaptysbio's Current Assets peaked at $553.9 million during Q4 2021, and registered a low of $291.9 million during Q2 2025.
- In the last 3 years, Anaptysbio's Current Assets had a median value of $406.8 million in 2023 and averaged $392.4 million.
- In the last 5 years, Anaptysbio's Current Assets skyrocketed by 39.67% in 2021 and then fell by 26.31% in 2025.
- Anaptysbio's Current Assets (Quarterly) stood at $553.9 million in 2021, then dropped by 19.26% to $447.2 million in 2022, then fell by 9.03% to $406.8 million in 2023, then rose by 6.16% to $431.9 million in 2024, then dropped by 26.31% to $330.6 million in 2025.
- Its Current Assets was $330.6 million in Q3 2025, compared to $291.9 million in Q2 2025 and $363.1 million in Q1 2025.